Status:

UNKNOWN

Pediatric Prospective Personalized Immune and Target Identification Trial

Lead Sponsor:

Masaryk University

Collaborating Sponsors:

Brno University Hospital

Roche s.r.o.

Conditions:

Central Nervous System Neoplasms

Pediatric Cancer

Eligibility:

All Genders

1-19 years

Phase:

NA

Brief Summary

PPROSPERITIT is a prospective clinical study assessing the use of comprehensive molecular profiling to define the best matching targeted and immune treatment for relapsed, refractory or very high risk...

Detailed Description

PPROSPERITIT will identify specific molecular changes by using genomic sequencing technologies in refractory/recurrent or very high-risk pediatric CNS tumors. The study will employ an analytically val...

Eligibility Criteria

Inclusion

  • Patient Informed consent form must be appropriately obtained under the applicable local and regulatory requirements. Each patient must sign a consent form prior the enrollment to document their willingness to participate.
  • The subject is male or female, aged 1 - 19 years
  • The subject must have a histologically proven recurrent/ refractory or very high-risk CNS tumors
  • Patients must be in good overall physical condition, which allows tumor biopsy
  • Patients must have a life expectancy of at least 3 months.
  • Patients must have a tumor amenable to image-guided or direct vision biopsy and be willing and able to undergo a tumor biopsy and/or blood taking for molecular profiling.
  • Patients must be accessible for follow-up.

Exclusion

  • Patients with known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
  • Pregnant and/or breastfeeding women, if applicable
  • No intention to treat the patient.

Key Trial Info

Start Date :

February 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2024

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT04859543

Start Date

February 1 2021

End Date

December 31 2024

Last Update

April 26 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University Hospital Brno

Brno, Czechia, 62500

2

Motol University Hospital

Prague, Czechia